SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029135
Filing Date
2018-11-13
Accepted
2018-11-13 08:01:37
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare-10q_20180930.htm 10-Q 1031476
2 EX-4.1 dare-ex41_345.htm EX-4.1 21237
3 EX-31.1 dare-ex311_9.htm EX-31.1 18642
4 EX-31.2 dare-ex312_18.htm EX-31.2 19159
5 EX-32.1 dare-ex321_11.htm EX-32.1 4701
6 EX-32.2 dare-ex322_16.htm EX-32.2 4791
7 GRAPHIC gl4iqqm5fy0t000001.jpg GRAPHIC 147455
  Complete submission text file 0001564590-18-029135.txt   4202455

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dare-20180930.xml EX-101.INS 622004
9 XBRL TAXONOMY EXTENSION SCHEMA dare-20180930.xsd EX-101.SCH 55531
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dare-20180930_cal.xml EX-101.CAL 29799
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dare-20180930_def.xml EX-101.DEF 139076
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE dare-20180930_lab.xml EX-101.LAB 342562
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dare-20180930_pre.xml EX-101.PRE 245475
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 181175221
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1